{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:11:31Z","timestamp":1790464291791,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404140"],"award-info":[{"award-number":["82404140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"innovation of science and technology of Fujian Province","award":["2020Y9022"],"award-info":[{"award-number":["2020Y9022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13992-3","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:13:52Z","timestamp":1754583232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of STAT3 and BIRC5 as anoikis-related biomarkers in psoriasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Wanting","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"4","key":"13992_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman, N. J. Management of psoriasis as a systemic disease: what is the evidence?. Br. J. Dermatol. 182(4), 840\u2013848. https:\/\/doi.org\/10.1111\/bjd.18245 (2020).","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"13992_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo, J. et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct. Target Ther. 8(1), 437. https:\/\/doi.org\/10.1038\/s41392-023-01655-6 (2023).","journal-title":"Signal Transduct. Target Ther."},{"issue":"10281","key":"13992_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. Psoriasis. Lancet 397(10281), 1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6 (2021).","journal-title":"Lancet"},{"issue":"10275","key":"13992_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/s0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., Balato, A., Enerb\u00e4ck, C. & Sabat, R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397(10275), 754\u2013766. https:\/\/doi.org\/10.1016\/s0140-6736(21)00184-7 (2021).","journal-title":"Lancet"},{"key":"13992_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184347","author":"K Kamiya","year":"2019","unstructured":"Kamiya, K., Kishimoto, M., Sugai, J., Komine, M. & Ohtsuki, M. Risk factors for the development of psoriasis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20184347 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"13992_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","author":"A Rendon","year":"2019","unstructured":"Rendon, A. & Schakel, K. Psoriasis pathogenesis and treatment. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20061475 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"13992_CR7","doi-asserted-by":"publisher","first-page":"3709749","DOI":"10.1155\/2020\/3709749","volume":"2020","author":"WM Wang","year":"2020","unstructured":"Wang, W. M. & Jin, H. Z. Role of neutrophils in psoriasis. J. Immunol. Res. 2020, 3709749. https:\/\/doi.org\/10.1155\/2020\/3709749 (2020).","journal-title":"J. Immunol. Res."},{"key":"13992_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.941071","volume":"13","author":"M Kamata","year":"2022","unstructured":"Kamata, M. & Tada, Y. Dendritic cells and macrophages in the pathogenesis of psoriasis. Front. Immunol. 13, 941071. https:\/\/doi.org\/10.3389\/fimmu.2022.941071 (2022).","journal-title":"Front. Immunol."},{"issue":"12","key":"13992_CR9","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41423-022-00940-8","volume":"19","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. The epidermal immune microenvironment plays a dominant role in psoriasis development, as revealed by mass cytometry. Cell Mol. Immunol. 19(12), 1400\u20131413. https:\/\/doi.org\/10.1038\/s41423-022-00940-8 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"13992_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773280","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Immune cell infiltration analysis demonstrates excessive mast cell activation in psoriasis. Front Immunol. 12, 773280. https:\/\/doi.org\/10.3389\/fimmu.2021.773280 (2021).","journal-title":"Front Immunol."},{"key":"13992_CR11","doi-asserted-by":"publisher","first-page":"1022986","DOI":"10.3389\/fimmu.2022.1022986","volume":"13","author":"XY Zhou","year":"2022","unstructured":"Zhou, X. Y., Chen, K. & Zhang, J. A. Mast cells as important regulators in the development of psoriasis. Front Immunol. 13, 1022986. https:\/\/doi.org\/10.3389\/fimmu.2022.1022986 (2022).","journal-title":"Front Immunol."},{"key":"13992_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca, C. et al. Role of the IL-23\/IL-17 pathway in rheumatic diseases: An overview. Front Immunol. 12, 637829. https:\/\/doi.org\/10.3389\/fimmu.2021.637829 (2021).","journal-title":"Front Immunol."},{"key":"13992_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312793","author":"R Singh","year":"2021","unstructured":"Singh, R., Koppu, S., Perche, P. O. & Feldman, S. R. The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms222312793 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"13992_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115603","volume":"167","author":"J He","year":"2023","unstructured":"He, J. et al. The role and application of three IFN-related reactions in psoriasis. Biomed. Pharmacother. 167, 115603. https:\/\/doi.org\/10.1016\/j.biopha.2023.115603 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"13992_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103465","volume":"28","author":"Y Tomar","year":"2023","unstructured":"Tomar, Y., Gorantla, S. & Singhvi, G. Insight into the pivotal role of signaling pathways in psoriasis pathogenesis, potential therapeutic molecules and drug delivery approaches. Drug Discov. Today. 28(2), 103465. https:\/\/doi.org\/10.1016\/j.drudis.2022.103465 (2023).","journal-title":"Drug Discov. Today."},{"key":"13992_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102916","volume":"133","author":"J Yu","year":"2022","unstructured":"Yu, J. et al. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J. Autoimmun. 133, 102916. https:\/\/doi.org\/10.1016\/j.jaut.2022.102916 (2022).","journal-title":"J. Autoimmun."},{"issue":"1","key":"13992_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms19010171","volume":"19","author":"E Calautti","year":"2018","unstructured":"Calautti, E., Avalle, L. & Poli, V. Psoriasis: A STAT3-Centric View. Int. J. Mol. Sci. 19(1), 171. https:\/\/doi.org\/10.3390\/ijms19010171 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"13992_CR18","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","volume":"42","author":"L Chen","year":"2021","unstructured":"Chen, L., Cao, S. Q., Lin, Z. M., He, S. J. & Zuo, J. P. NOD-like receptors in autoimmune diseases. Acta Pharmacol Sin. 42(11), 1742\u20131756. https:\/\/doi.org\/10.1038\/s41401-020-00603-2 (2021).","journal-title":"Acta Pharmacol Sin."},{"key":"13992_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106689","volume":"86","author":"WJ Zhu","year":"2020","unstructured":"Zhu, W. J., Li, P., Wang, L. & Xu, Y. C. Hypoxia-inducible factor-1: A potential pharmacological target to manage psoriasis. Int. Immunopharmacol. 86, 106689. https:\/\/doi.org\/10.1016\/j.intimp.2020.106689 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl 2","key":"13992_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","volume":"12","author":"AP Gilmore","year":"2005","unstructured":"Gilmore, A. P. Anoikis. Cell Death Differ. 12(Suppl 2), 1473\u20131477. https:\/\/doi.org\/10.1038\/sj.cdd.4401723 (2005).","journal-title":"Cell Death Differ."},{"issue":"12","key":"13992_CR21","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli, P., Giannoni, E. & Chiarugi, P. Anoikis molecular pathways and its role in cancer progression. Biochim. Biophys. Acta. 1833(12), 3481\u20133498. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.06.026 (2013).","journal-title":"Biochim. Biophys. Acta."},{"issue":"2","key":"13992_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei, M. L., Giannoni, E., Fiaschi, T. & Chiarugi, P. Anoikis: An emerging hallmark in health and diseases. J Pathol. 226(2), 380\u2013393. https:\/\/doi.org\/10.1002\/path.3000 (2012).","journal-title":"J Pathol."},{"key":"13992_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626577","volume":"11","author":"FO Adeshakin","year":"2021","unstructured":"Adeshakin, F. O. et al. Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol. 11, 626577. https:\/\/doi.org\/10.3389\/fonc.2021.626577 (2021).","journal-title":"Front Oncol."},{"key":"13992_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.critrevonc.2019.05.009","volume":"140","author":"A Tajbakhsh","year":"2019","unstructured":"Tajbakhsh, A., Rivandi, M., Abedini, S., Pasdar, A. & Sahebkar, A. Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review. Crit. Rev. Oncol. Hematol. 140, 17\u201327. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.05.009 (2019).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"13992_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.976557","volume":"12","author":"Z Zhu","year":"2022","unstructured":"Zhu, Z. et al. Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future. Front Oncol. 12, 976557. https:\/\/doi.org\/10.3389\/fonc.2022.976557 (2022).","journal-title":"Front Oncol."},{"issue":"8","key":"13992_CR26","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s00262-021-02867-x","volume":"70","author":"YF Tsai","year":"2021","unstructured":"Tsai, Y. F. et al. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis. Cancer Immunol Immunother. 70(8), 2339\u20132351. https:\/\/doi.org\/10.1007\/s00262-021-02867-x (2021).","journal-title":"Cancer Immunol Immunother."},{"issue":"5","key":"13992_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12032-022-01664-5","volume":"39","author":"M Karavyraki","year":"2022","unstructured":"Karavyraki, M. & Porter, R. K. Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma. Med Oncol. 39(5), 60. https:\/\/doi.org\/10.1007\/s12032-022-01664-5 (2022).","journal-title":"Med Oncol."},{"issue":"1","key":"13992_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12964-023-01247-5","volume":"21","author":"YH Han","year":"2023","unstructured":"Han, Y. H. et al. Regulation of anoikis by extrinsic death receptor pathways. Cell Commun. Signal 21(1), 227. https:\/\/doi.org\/10.1186\/s12964-023-01247-5 (2023).","journal-title":"Cell Commun. Signal"},{"issue":"16","key":"13992_CR29","doi-asserted-by":"publisher","first-page":"7051","DOI":"10.18632\/oncotarget.2251","volume":"5","author":"NM Fofaria","year":"2014","unstructured":"Fofaria, N. M. & Srivastava, S. K. Critical role of STAT3 in melanoma metastasis through anoikis resistance. Oncotarget 5(16), 7051\u20137064. https:\/\/doi.org\/10.18632\/oncotarget.2251 (2014).","journal-title":"Oncotarget"},{"issue":"1","key":"13992_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/carcin\/bgu233","volume":"36","author":"NM Fofaria","year":"2015","unstructured":"Fofaria, N. M. & Srivastava, S. K. STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells. Carcinogenesis 36(1), 142\u2013150. https:\/\/doi.org\/10.1093\/carcin\/bgu233 (2015).","journal-title":"Carcinogenesis"},{"issue":"D1","key":"13992_CR31","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucl. Acids Res. 53(D1), D672-d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucl. Acids Res."},{"key":"13992_CR32","doi-asserted-by":"publisher","first-page":"1265517","DOI":"10.3389\/fimmu.2023.1265517","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Integrative single-cell transcriptomic investigation unveils long non-coding RNAs associated with localized cellular inflammation in psoriasis. Front Immunol. 14, 1265517. https:\/\/doi.org\/10.3389\/fimmu.2023.1265517 (2023).","journal-title":"Front Immunol."},{"issue":"1","key":"13992_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/0471250953.bi0814s24","volume":"24","author":"GM Morris","year":"2008","unstructured":"Morris, G. M., Huey, R. & Olson, A. J. Using AutoDock for ligand-receptor docking. Curr. Protoc. Bioinf. 24(1), 8\u201314. https:\/\/doi.org\/10.1002\/0471250953.bi0814s24 (2008).","journal-title":"Curr. Protoc. Bioinf."},{"issue":"D1","key":"13992_CR34","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","volume":"45","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. PubChem BioAssay: 2017 update. Nucl. Acids Res. 45(D1), D955-d963. https:\/\/doi.org\/10.1093\/nar\/gkw1118 (2017).","journal-title":"Nucl. Acids Res."},{"issue":"12","key":"13992_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083922","volume":"8","author":"KY Hsin","year":"2013","unstructured":"Hsin, K. Y., Ghosh, S. & Kitano, H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS ONE 8(12), e83922. https:\/\/doi.org\/10.1371\/journal.pone.0083922 (2013).","journal-title":"PLoS ONE"},{"issue":"12","key":"13992_CR36","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.jid.2023.04.035","volume":"143","author":"M Liu","year":"2023","unstructured":"Liu, M. et al. FOXE1 contributes to the development of psoriasis by regulating WNT5A. J. Invest. Dermatol. 143(12), 2366\u20132377. https:\/\/doi.org\/10.1016\/j.jid.2023.04.035 (2023).","journal-title":"J. Invest. Dermatol."},{"key":"13992_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106751","volume":"86","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. Cytotoxicity of Saikosaponin A targets HEKa cell through apoptosis induction by ROS accumulation and inflammation suppression via NF-kappaB pathway. Int Immunopharmacol. 86, 106751. https:\/\/doi.org\/10.1016\/j.intimp.2020.106751 (2020).","journal-title":"Int Immunopharmacol."},{"issue":"10","key":"13992_CR38","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.jid.2018.12.035","volume":"139","author":"B Li","year":"2019","unstructured":"Li, B. et al. Dysregulation of Akt-FOXO1 pathway leads to dysfunction of regulatory T cells in patients with psoriasis. J. Invest. Dermatol. 139(10), 2098\u20132107. https:\/\/doi.org\/10.1016\/j.jid.2018.12.035 (2019).","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"13992_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/scd.2019.0150","volume":"29","author":"G Ali","year":"2020","unstructured":"Ali, G. et al. Keratinocytes derived from patient-specific induced pluripotent stem cells recapitulate the genetic signature of psoriasis disease. Stem Cells Dev. 29(7), 383\u2013400. https:\/\/doi.org\/10.1089\/scd.2019.0150 (2020).","journal-title":"Stem Cells Dev."},{"key":"13992_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222112035","author":"HJ Lee","year":"2021","unstructured":"Lee, H. J., Hong, Y. J. & Kim, M. Angiogenesis in chronic inflammatory skin disorders. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms222112035 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"13992_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska, I., Pieniawska, M. & Grzywa, T. M. the immunology of psoriasis-current concepts in pathogenesis. Clin. Rev. Allergy Immunol. 66(2), 164\u2013191. https:\/\/doi.org\/10.1007\/s12016-024-08991-7 (2024).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"13992_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/inmd.20230056","author":"H Xie","year":"2024","unstructured":"Xie, H., Jia, Y. & Liu, S. Integration of artificial intelligence in clinical laboratory medicine: Advancements and challenges. Interdiscip. Med. https:\/\/doi.org\/10.1002\/inmd.20230056 (2024).","journal-title":"Interdiscip. Med."},{"issue":"5","key":"13992_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajpath.2023.01.016","volume":"193","author":"W Huang","year":"2023","unstructured":"Huang, W. et al. Protein kinase CK2 promotes proliferation, abnormal differentiation, and proinflammatory cytokine production of keratinocytes via regulation of STAT3 and Akt pathways in psoriasis. Am. J. Pathol. 193(5), 567\u2013578. https:\/\/doi.org\/10.1016\/j.ajpath.2023.01.016 (2023).","journal-title":"Am. J. Pathol."},{"key":"13992_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155535","volume":"144","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. STAT3\/SH3PXD2A-AS1\/miR-125b\/STAT3 positive feedback loop affects psoriasis pathogenesis via regulating human keratinocyte proliferation. Cytokine 144, 155535. https:\/\/doi.org\/10.1016\/j.cyto.2021.155535 (2021).","journal-title":"Cytokine"},{"key":"13992_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/inmd.20230021","author":"H Bao","year":"2023","unstructured":"Bao, H., Min, L., Bu, F., Wang, S. & Meng, J. Recent advances of liquid biopsy: Interdisciplinary strategies toward clinical decision-making. Interdiscip. Med. https:\/\/doi.org\/10.1002\/inmd.20230021 (2023).","journal-title":"Interdiscip. Med."},{"issue":"16","key":"13992_CR46","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.7150\/jca.58670","volume":"12","author":"FO Adeshakin","year":"2021","unstructured":"Adeshakin, F. O. et al. Upregulation of V-ATPase by STAT3 activation promotes anoikis resistance and tumor metastasis. J Cancer 12(16), 4819\u20134829. https:\/\/doi.org\/10.7150\/jca.58670 (2021).","journal-title":"J Cancer"},{"issue":"5","key":"13992_CR47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-022-04890-x","volume":"13","author":"LN Wang","year":"2022","unstructured":"Wang, L. N. et al. TGF-beta1\/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2\/STAT3 and SHP2\/Grb2 signaling pathways. Cell Death Dis. 13(5), 472. https:\/\/doi.org\/10.1038\/s41419-022-04890-x (2022).","journal-title":"Cell Death Dis."},{"key":"13992_CR48","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.2147\/OTT.S240081","volume":"13","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Yin, M., Wang, R., Liu, X. & Yan, D. Bit1 silencing enhances the proliferation, migration, and invasion of glioma cells through activation of the IL-6\/STAT3 pathway. Onco. Targets Ther. 13, 2469\u20132481. https:\/\/doi.org\/10.2147\/OTT.S240081 (2020).","journal-title":"Onco. Targets Ther."},{"issue":"11","key":"13992_CR49","doi-asserted-by":"publisher","first-page":"19440","DOI":"10.1002\/jcp.28725","volume":"234","author":"Y Pahlavan","year":"2019","unstructured":"Pahlavan, Y. et al. Survivin modulatory role in autoimmune and autoinflammatory diseases. J. Cell Physiol. 234(11), 19440\u201319450. https:\/\/doi.org\/10.1002\/jcp.28725 (2019).","journal-title":"J. Cell Physiol."},{"issue":"8","key":"13992_CR50","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1535-7163.MCT-19-1166","volume":"19","author":"S Dimitrov-Markov","year":"2020","unstructured":"Dimitrov-Markov, S. et al. Discovery of new targets to control metastasis in pancreatic cancer by single-cell transcriptomics analysis of circulating tumor cells. Mol. Cancer Ther. 19(8), 1751\u20131760. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-1166 (2020).","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"13992_CR51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12885-022-09500-9","volume":"22","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. BIRC5 regulates inflammatory tumor microenvironment-induced aggravation of penile cancer development in vitro and in vivo. BMC Cancer 22(1), 448. https:\/\/doi.org\/10.1186\/s12885-022-09500-9 (2022).","journal-title":"BMC Cancer"},{"issue":"1","key":"13992_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2006.12.020","volume":"249","author":"MJ Duffy","year":"2007","unstructured":"Duffy, M. J., O\u2019Donovan, N., Brennan, D. J., Gallagher, W. M. & Ryan, B. M. Survivin: a promising tumor biomarker. Cancer Lett. 249(1), 49\u201360. https:\/\/doi.org\/10.1016\/j.canlet.2006.12.020 (2007).","journal-title":"Cancer Lett."},{"key":"13992_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.omtn.2021.03.011","volume":"24","author":"J Sadri Nahand","year":"2021","unstructured":"Sadri Nahand, J. et al. Cell death pathways and viruses: Role of microRNAs. Mol. Ther. Nucl. Acids. 24, 487\u2013511. https:\/\/doi.org\/10.1016\/j.omtn.2021.03.011 (2021).","journal-title":"Mol. Ther. Nucl. Acids."},{"issue":"1","key":"13992_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-017-0582-2","volume":"16","author":"CS Mak","year":"2017","unstructured":"Mak, C. S. et al. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12\/Sp1\/survivin axis. Mol. Cancer. 16(1), 11. https:\/\/doi.org\/10.1186\/s12943-017-0582-2 (2017).","journal-title":"Mol. Cancer."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13992-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13992-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13992-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:02:05Z","timestamp":1754629325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13992-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13992"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13992-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving humans were approved by Ethics Committee of Xi \u2018an Jiaotong University. The studies were conducted in accordance with the local legislation and institutional requirements (No. LLSBPJ-2024\u2013215). The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"28929"}}